Hello,
Welcome to Insider
- We ranked the top biotech investors of 2021 who are poised to dominate next year too;
- Included Health is gearing up for an IPO early next year;
- Meet Virtue, a new investor fund for digital health.
If you're new to this
Here are the 18 investors set to shape biotech in 2022
- Insider analyzed more than 90 IPOs to find the top venture-capital firms that led
biotech in 2021. - Arch, Novo Holdings, and Flagship Pioneering topped the list with more than $1 billion in equity.
- Several firms have already raised new funds and laid out investment plans for next year.
Exclusive: Grand Rounds, now Included Health, is gearing up for an IPO in early 2022
- Included Health has hired firms to gear up for an
IPO , four people told Insider. - In 2021, the health startups Grand Rounds Health and Doctor on Demand merged to form Included.
- The company offers services such as mental-health care and specialty referrals.
Health systems and insurance companies are investing in first-time funds like the newly minted firm Virtue to capitalize on the digital health boom
- The investor Sean Doolan is launching
Virtue , his first solo fund, with $31.25 million in funding. - Doolan previously invested in healthcare companies in his role at Global Founders Capital.
- He told Insider the booming industry needed smaller and faster investors.
More stories we're reading:
- SoftBank just invested $300 million in the mental-health startup Cerebral. The lead investor told us about how he plans to steer the mega-VC toward more digital-health deals. (Insider)
- An inside look at Biogen's leadership disaster in the wake of the Aduhelm approval (STAT)
- Scientists found a 2nd type of Omicron that's harder to track since tests struggle to distinguish it from other variants (Insider)
- How the COVID-19 virus could mutate next (Nature)
- A top CVS Health exec breaks down the 4 ways the company is using technology to transform how patients get care and prescriptions (Insider)
-Leah